12 research outputs found
Modelling the progression of competitive performance of an academy's soccer teams
Progression of a teamâs performance is a key issue in competitive sport, but there appears to have been no published research on team progression for periods longer than a season. In this study we report the game-score progression of three teams of a youth talent-development academy over five seasons using a novel analytic approach based on generalised mixed modelling. The teams consisted of players born in 1991, 1992 and 1993; they played totals of 115, 107 and 122 games in Asia and Europe between 2005 and 2010 against teams differing in age by up to 3 years. Game scores predicted by the mixed model were assumed to have an over-dispersed Poisson distribution. The fixed effects in the model estimated an annual linear pro-gression for Aspire and for the other teams (grouped as a single opponent) with adjustment for home-ground advantage and for a linear effect of age difference between competing teams. A random effect allowed for different mean scores for Aspire and opposition teams. All effects were estimated as factors via log-transformation and presented as percent differences in scores. Inferences were based on the span of 90% confidence intervals in relation to thresholds for small factor effects of x/Ă·1.10 (+10%/-9%). Most effects were clear only when data for the three teams were combined. Older teams showed a small 27% increase in goals scored per year of age difference (90% confidence interval 13 to 42%). Aspire experienced a small home-ground advantage of 16% (-5 to 41%), whereas opposition teams experienced 31% (7 to 60%) on their own ground. After adjustment for these effects, the Aspire teams scored on average 1.5 goals per match, with little change in the five years of their existence, whereas their opponentsâ scores fell from 1.4 in their first year to 1.0 in their last. The difference in progression was trivial over one year (7%, -4 to 20%), small over two years (15%, -8 to 44%), but unclear over >2 years. In conclusion, the generalized mixed model has marginal utility for estimating progression of soccer scores, owing to the uncertainty arising from low game scores. The estimates are likely to be more precise and useful in sports with higher game scores
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
Objective: To describe people with gout who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized and to characterize their outcomes. Methods: Data on patients with gout hospitalized for COVID-19 between March 12, 2020, and October 25, 2021, were extracted from the COVID-19 Global Rheumatology Alliance registry. Descriptive statistics were used to describe the demographics, comorbidities, medication exposures, and COVID-19 outcomes including oxygenation or ventilation support and death. Results: One hundred sixty-three patients with gout who developed COVID-19 and were hospitalized were included. The mean age was 63 years, and 85% were male. The majority of the group lived in the Western Pacific Region (35%) and North America (18%). Nearly half (46%) had two or more comorbidities, with hypertension (56%), cardiovascular disease (28%), diabetes mellitus (26%), chronic kidney disease (25%), and obesity (23%) being the most common. Glucocorticoids and colchicine were used pre-COVID-19 in 11% and 12% of the cohort, respectively. Over two thirds (68%) of the cohort required supplemental oxygen or ventilatory support during hospitalization. COVID-19-related death was reported in 16% of the overall cohort, with 73% of deaths documented in people with two or more comorbidities. Conclusion: This cohort of people with gout and COVID-19 who were hospitalized had high frequencies of ventilatory support and death. This suggests that patients with gout who were hospitalized for COVID-19 may be at risk of poor outcomes, perhaps related to known risk factors for poor outcomes, such as age and presence of comorbidity
Using athletes' world rankings to assess countries' performance
There is a need for fair measures of country sport performance that include athletes who do not win medals.Purpose:To develop a measure of country performance based on athlete ranks in the sport of swimming.Methods:Annual top-150 ranks in Olympic pool-swimming events were downloaded for 1990 through 2011. For each athlete of a given rank, a score representing the athleteâs performance potential was estimated as the proportion of athletes of that rank who ever achieved top rank. A countryâs scores were calculated by summing its athletesâ scores over all 32 events. Reliability and convergent validity were assessed via year-to-year correlations and correlations with medal counts at major competitions. The method was also applied to ranks at the 2012 Olympics to evaluate countriesâ swimming performance.Results:The performance score of an athlete of a given rank was closely approximated by 1/rank. This simpler score has 1 practical interpretation: An athlete ranked 7th (for example) has a chance of 1/7 of ever achieving top rank; for purposes of evaluating country performance, 7 such athletes are equivalent to 1 athlete of the top rank. Country scores obtained by summing 1/rank of the countryâs athletes had high reliability and validity. This approach produced scores for 168 countries at the Olympics, whereas only 17 countries won medals.Conclusions:The authors used the sport of swimming to develop a fair and inclusive measure representing a countryâs performance potential. This measure should be suitable for assessing countries in any sports with world rankings or with athletes at major competitions.</jats:sec
The reliability and usefulness of an individualised submaximal shuttle run test in elite rugby league players
Purpose: The aim of the present study was to examine the reliability and usefulness of a proposed 4-min individualised submaximal shuttle run test (SSR) in elite rugby league players. Materials and methods: Twenty-two elite rugby league players competing in the National Rugby League competition (23.2\ua0±\ua03.4\ua0years, 186.8\ua0±\ua05.4\ua0cm, 100.2\ua0±\ua08.5\ua0kg) performed the SSR twice, seven days apart (testâretest design). The SSR was prescribed as 75% of the average speed during a 1500-m time trial. Exercise heart rate was calculated as the average heart rate (HR) over the final 30 s (HRex). Seated HR recovery (HRR) was recorded at 1- (HRR) and 2-min (HRR) post-exercise. Data were analysed with magnitude-based inferences. Results: Testâretest typical errors were moderate for HRex (1.2 percentage points; 90% confidence limits: 1.0â1.7), HRR (3.4; 2.7â4.6) and HRR (2.9; 2.3â3.9). Intraclass correlation coefficients were extremely high for HRex (0.91; 0.78â0.94) and very high for both HRR (0.80; 0.61â0.90) and HRR (0.84; 0.69â0.92). Thresholds for an individual change that would be likely small and greater than the typical error were ±1.8 (percentage points), ±4.6 and ±4.1 for HRex, HRR and HRR, respectively. Conclusions: The SSR demonstrates acceptable reliability in the assessment of HRex and HRR, thus demonstrating its potential usefulness for monitoring fitness and fatigue in elite rugby league players
Practical Issues in Evidence-Based Use of Performance Supplements: Supplement Interactions, Repeated Use and Individual Responses
Current sports nutrition guidelines recommend that athletes only take supplements following an evidence-based analysis of their value in supporting training outcomes or competition performance in their specific event. While there is sound evidence to support the use of a few performance supplements under specific scenarios (creatine, beta-alanine, bicarbonate, caffeine, nitrate/beetroot juice and, perhaps, phosphate), there is a lack of information around several issues needed to guide the practical use of these products in competitive sport. First, there is limited knowledge around the strategy of combining the intake of several products in events in which performance benefits are seen with each product in isolation. The range in findings from studies involving combined use of different combinations of two supplements makes it difficult to derive a general conclusion, with both the limitations of individual studies and the type of sporting event to which the supplements are applied influencing the potential for additive, neutral or counteractive outcomes. The repeated use of the same supplement in sports involving two or more events within a 24-h period is of additional interest, but has received even less attention. Finally, the potential for individual athletes to respond differently, in direction and magnitude, to the use of a supplement seems real, but is hard to distinguish from normal day to day variability in performance. Strategies that can be used in research or practice to identify whether individual differences are robust include repeat trials, and the collection of data on physiological or genetic mechanisms underpinning outcomes